IOM Report Urges FDA Shift from 510(k) Program | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) –The Institute of Medicine today proposed that the US Food and Drug Administration effectively scrap its 35 year-old 510(k) medical devices clearance program in favor of a hybrid model that would mix pre-market and post-market review activities in order to better protect consumers and promote innovation.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.